Lumizyme Approval History
- FDA approved: Yes (First approved May 24th, 2010)
- Brand name: Lumizyme
- Generic name: alglucosidase alfa
- Company: Genzyme Corporation
- Treatment for: Pompe disease
Lumizyme (alglucosidase alfa) is a lysosomal glycogen-specific enzyme indicated for patients 8 years and older with late (non-infantile) onset Pompe disease.
FDA Approval History for Lumizyme
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.